Nu har en grupp brittiska forskare visat att en mutation i genen ATP1A3 ger upphov till en allvarlig form av epilepsi hos möss. Studien leddes av Steve Clapcote vid Universitetet i Leeds.
Proteinet som ATP1A3 kodar för är ett enzym som är involverat i regleringen av natrium-kaliumhalten i hjärnan genom att pumpa kemikalierna in och ut ur cellen. Koncentrationen av natrium och kalium i nervcellerna avgör hur lätt nervsignaler skickas iväg och en obalans i nivåerna kan trigga igång onormalt mycket nervimpulser vilket får kroppens muskler att krampa.
Forskarna har nu börjat screena genetiskt material från epilepsipatienter för att se om samma genetiska defekt ökar risken att drabbas av sjukdomen hos människor. Om detta visar sig vara fallet kan de nya rönen komma att öppna dörren för nya behandlingar. Kanske skulle patienterna kunna behandlas med en syntetisk version av natrium- kaliumpumpen för att återsälla regleringen av kemikalierna i hjärnan.

































"To support research within diabetes and cardiovascular diseases with first class unique diagnostic tests"
"Innovation for people. We design and develop devices for the end-user."
"We are entirely devoted to luminescence technology."
"Novel products for CVD treatment and prevention."
"We have a unique technological platform, built around 5HT-receptor antagonism, for the treatment of inflammation and pain"."
"Dilafor was founded by 12 experts, which operate in Dilafor within their field of expertise, complemented by purchasing services."
"Our mission is to become a natural partner in storage of valuable samples."
"We turn medical research into applications for better health and well-being."
"Our organisation value is to contribute to positioning Scandinavian healthcare and research in absolute world class."
"TFS is today the leading European development partner for biopharmaceutical companies in their global clinical development process."
"APL provides high-quality services to Life Science. We are a Dedicated Partner from Discovery to Market."
"Our services in ligand-based and structure-based drug design is a cost-efficient alternative for smaller pharmaceutical companies"
"We offer effective staffing solutions provided by specialists, we understand a company’s specific needs and we know where to find the best talent."
"To adapt Competent Authorities´ requirements into opportunities is not just an artform - today it´s a business necessity."
"Uppsala BIO is a life science pathfinder. We build ways to make life science flourish, in cooperation with industry, academia, society and healthcare."
"Your global partner of pharmaceutical service and cGMP manufacturing"
"Our reliability, customer service, global network and integrated technology make World Courier service truly "A service no one else can deliver"."
"PCG - a professional full service CRO for your clinical trials.
Powered by Viedoc, globally trusted eCRF, keeping trials within budget and timelines"
"To be the most attractive node and business platform in the Nordic countries for new and innovative Life Science companies"
"Kovalent AB´s intention is to be the most support-intensive distributor of laboratory equipment in Scandinavia."
"Discover your possibilities in one of Europe´s most productive life science regions. Welcome to Stockholm-Uppsala Life Science."
"As a full service CRO with offices in all Nordic countries we can provide our customer with professional support throughout the clinical research."
"VWR is a global laboratory distributor of chemicals, life science products, consumables, equipment, instruments, furniture, e-commerce and services"
"With our first class products and our committed and skilled colleagues we guarantee our customers the best support in the market, at no extra charge."
"Karolinska Development aims to create value by developing innovations from world class research into products that can be exited with high returns."
"To supply Swedish and Danish laboratories with laboratory equipment and furniture of highest quality and offer service on all delivered products."
"To develop innovative and effective pharmaceuticals within autoimmune/ inflammatory diseases and cancer where major medical need exists"
"We are recognized as a flexible partner with short decision and lead times plus a proven record for the highest quality and cost efficiency." 
